ABSTRACT We present a case of Retinal Cavernous Haemangioma treated with Intravitreal Bevacizumab, which was initially labelled as persistent proliferative diabetic retinopathy with multiple episodes of vitreous haemorrhage. These lesions can be confused with new retinal vessels in diabetics and if correctly diagnosed unnecessary photocoagulation can be avoided. Our patient received a course of three intravitreal Bevacizumab injections (1.25 mg/0.05 ml) in order to stop the leakage from the retinal cavernous haemangioma lesions and prevent another episode of vitreous haemorrhage. No intraoperative or postoperative complications were seen. Twenty-two months following treatment there was no recurrence of vitreous haemorrhage.
Cite this paper
M. Tsagkataki, A. Khalil and A. Kamal, "Another Proliferative Diabetic Retinopathy? A Case Report of Retinal Cavernous Haemangioma Treated with Intravitreal Bevacizumab, Initially Labelled as Persistent Proliferative Diabetic Retinopathy," Open Journal of Ophthalmology, Vol. 2 No. 1, 2012, pp. 5-7. doi: 10.4236/ojoph.2012.21002.
 E. Pringle, S. Chen, A. Rubinstein, C. K. Patel and S. Downes, “Optical Coherence Tomography in Retinal Cavernous Haemangioma may Explain the Mechanism of Vitreous Haemorrhage,” Eye, Vol. 23, 2009, pp. 1242-1243.
P. Labauge, V. Krivosic, C. Denier, E. Tounier-Lasserve and A. Gaudric, “Frequency of Retinal Cavernomas in 60 Patients with Familial Cerebral Cavernomas: A Clinical and Genetic Study,” Archives of Ophthalmology, Vol. 124, No. 6, 2006, pp. 885-886.
H. Heimann and B. Damato, “Congenital Vascular Malformations of the Retina and Choroid,” Eye, Vol. 24, No. 3, 2010, pp. 459-467. doi:10.1038/eye.2009.310
A. D. Singh, P. A. Rundle and I. Rennie, “Retinal Vascular Tumors,” Ophthalmology Clinics of North America, Vol. 18, No. 1, 2005, pp. 167-176.